Terry et al. performed a prospective cohort study including 17.917 breast cancer patients (7.2% positive for BRCA1 and BRCA2 gene mutations) and concluded that prophylactic SO was not considered effective in reducing the risk of breast cancer [26]. This evidence concerns the gene BRCA2 and breast cancer.